Increased NM23H1 Copy Number as a Prognostic Factor in Neuroblastomas
Author Information
Author(s): Takedal, M Handa, T Uehara, N Maseki, A Sakashita, M Sakurai, N Kanda, Y Arai, Y Kaneko
Primary Institution: Saitama Cancer Center Hospital
Hypothesis
An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on lp in neuroblastomas.
Conclusion
The study suggests that an increased NM23H1 copy number may predict poor prognosis in neuroblastoma patients.
Supporting Evidence
- Event-free survival (EFS) was significantly shorter in patients with LOH on lp compared to those without.
- Patients with increased NM23H1 copy numbers had a shorter EFS than those with normal copy numbers.
- Most tumors with increased NM23H1 copy numbers occurred in patients aged 12 months or more.
Takeaway
This study found that having more copies of a specific gene (NM23H1) in neuroblastoma tumors can mean a worse outcome for kids with this cancer.
Methodology
The study analyzed tissue samples from 154 neuroblastomas for loss of heterozygosity (LOH) and NM23H1 copy number, correlating these with event-free survival (EFS).
Limitations
The study may have included a large number of patients found by mass screening, which could affect the incidence rates reported.
Participant Demographics
Patients were Japanese infants and children aged between 10 days and 9 years.
Statistical Information
P-Value
0.0093
Statistical Significance
p=0.0093
Want to read the original?
Access the complete publication on the publisher's website